Scarica l'app Stockscreener
85.71
0.33%
-0.28
Pre-mercato:
86.00
0.29
+0.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$85.99
Aprire:
$85.4
Volume 24 ore:
1.75M
Relative Volume:
0.80
Capitalizzazione di mercato:
$16.99B
Reddito:
$8.01B
Utile/perdita netta:
$807.20M
Rapporto P/E:
21.21
EPS:
4.0411
Flusso di cassa netto:
$1.13B
1 W Prestazione:
-0.97%
1M Prestazione:
-5.57%
6M Prestazione:
-10.70%
1 anno Prestazione:
-23.38%
Intervallo 1D:
$84.91
$86.33
Intervallo di 1 settimana:
$84.91
$88.60
Portata 52W:
$84.91
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
85.71 | 17.04B | 8.01B | 807.20M | 1.13B | 4.0411 |
|
ABT
Abbott Laboratories
|
106.05 | 188.27B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.79 | 138.83B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
357.83 | 135.60B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.79 | 129.09B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
81.86 | 48.51B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Downgrade | Goldman | Neutral → Sell |
| 2026-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet (NYSE:ZBH) Sets New 52-Week LowHere's What Happened - MarketBeat
Expert Outlook: Zimmer Biomet Holdings Through The Eyes Of 13 Analysts - Benzinga
Zimmer Biomet stock hits 52-week low at $85.15 - Investing.com
Market Leaders: What is the dividend yield of Zimmer Biomet Holdings IncTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn
ZBH.SW Zimmer Biomet (SIX) spikes to CHF67.50 pre-market 28 Jan 2026: monitor liquidity - Meyka
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution - PR Newswire
TD Cowen assumes coverage on Zimmer Biomet stock with Buy rating - Investing.com Nigeria
Global Arthroscopy Devices Market is Expected to Expand at a Healthy Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.
What Analysts Think Is Reframing Zimmer Biomet (ZBH) Story For Investors - Yahoo Finance
Zimmer Biomet Holdings (ZBH)’s 2026 expectations remain cautious amid internal reset - MSN
3 New 5-Star Stocks This Week - Morningstar
Decliners Report: Is Zimmer Biomet Holdings Inc exposed to currency risksJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - baoquankhu1.vn
Support Test: Is FBNC stock overvalued or fairly priced2025 Year in Review & Smart Investment Allocation Insights - baoquankhu1.vn
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by Sector Gamma AS - MarketBeat
Strs Ohio Cuts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ARGA Investment Management LP Acquires Shares of 154,539 Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
How Investors May Respond To Zimmer Biomet (ZBH) Cautious 2026 Outlook And Executive Departure - simplywall.st
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) - GlobeNewswire
Report: Zimmer Biomet planning layoffs - insideindianabusiness.com
The Truth About Zimmer Biomet Stock: Silent Boom Or Boring Boomer Play? - AD HOC NEWS
Zimmer Biomet launches new foot and ankle system - MassDevice
Bone Growth Stimulator Market Covering Prime Factors - openPR.com
Rakuten Investment Management Inc. Makes New $37.31 Million Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (ZBH)’s 2026 Expectations Remain Cautious Amid Internal Reset - Insider Monkey
Q3 Rundown: Zimmer Biomet (NYSE:ZBH) Vs Other Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
Income Plays: Is CAPS currently under institutional pressureEarnings Risk Summary & Weekly High Potential Alerts - baoquankhu1.vn
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - Intellectia AI
Short Interest in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Rises By 33.0% - MarketBeat
Is It Time To Reassess Zimmer Biomet (ZBH) After Prolonged Share Price Weakness - Yahoo Finance
Zimmer Biomet (ZBH) Valuation Check After Cautious Guidance At J.P. Morgan Healthcare Conference - Sahm
Minneapolis Portfolio Management Group LLC Has $26.02 Million Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet granted CE Mark for RibFix Advantage Fixation System - MSN
Zimmer Biomet (NYSE:ZBH) Upgraded to Buy at Wall Street Zen - MarketBeat
Zimmer Biomet (ZBH) Mixes Executive Exit With Big DTC Push Is Management Rewriting Its Playbook? - simplywall.st
Goldman Sachs Adjusts Price Target on Zimmer Biomet to $88 From $93, Maintains Sell Rating - marketscreener.com
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results - BioSpace
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock - sharewise.com
What is the dividend yield of Zimmer Biomet Holdings IncQuarterly Trade Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Buyback Watch: What is the dividend yield of Zimmer Biomet Holdings Inc2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Zimmer Biomet’s Q3 2025 earnings: What to expect - MSN
Zimmer Biomet Announces Webcast and Conference Call of Fourth Qu - GuruFocus
Zimmer Biomet Announces Q4 2026 Earnings Call Date - Intellectia AI
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)? - Yahoo Finance
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - MSN
JPM26: Zimmer Biomet in midst of largest patient campaign in its history - Yahoo Finance
Zimmer Biomet (ZBH) Ensures Cautious Outlook for 2026 Transforma - GuruFocus
Zimmer Biomet (ZBH) Cautions Investors Ahead of Earnings Release - GuruFocus
Zimmer Biomet drops after cautious remarks on outlook - MSN
Zimmer Biomet down after cautious remarks on outlook (ZBH:NYSE) - Seeking Alpha
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):